Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis

Add time:08/30/2019    Source:sciencedirect.com

Biphenylacetic acid (5) was identified through a library screen as an inhibitor of the prostaglandin D2 receptor DP2 (CRTH2). Optimization for potency and pharmacokinetic properties led to a series of selective CRTH2 antagonists. Compounds demonstrated potency in a human DP2 binding assay and a human whole blood eosinophil shape change assay, as well as good oral bioavailability in rat and dog, and efficacy in a mouse model of allergic rhinitis following oral dosing.

We also recommend Trading Suppliers and Manufacturers of 3,5-DIFLUORO-4-(TRIFLUOROMETHYL)PHENYLACETIC ACID (cas 132992-26-8). Pls Click Website Link as below: cas 132992-26-8 suppliers

Prev:Electrochemical direct carboxylation of benzyl alcohols having an electron-withdrawing group on the phenyl ring: one-step formation of phenylacetic acids from benzyl alcohols under mild conditions
Next:Research paperSynthesis and biological evaluation of 4-(2-fluorophenoxy)-3,3′-bipyridine derivatives as potential c-met inhibitors)